Carroll Investors Inc increased its stake in UiPath Inc. (NYSE:PATH – Free Report) by 13.7% in the 1st quarter, Holdings Channel.com reports. The fund owned 82,803 shares of the healthcare company’s stock after acquiring an additional 10,002 shares during the quarter. UiPath comprises approximately 1.4% of Carroll Investors Inc’s investment portfolio, making the stock its 15th biggest position. Carroll Investors Inc’s holdings in UiPath were worth $1,878,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Mark Sheptoff Financial Planning LLC purchased a new stake in UiPath in the 4th quarter worth $25,000. HighMark Wealth Management LLC purchased a new stake in UiPath in the 4th quarter worth $27,000. Cypress Capital Management LLC WY purchased a new stake in UiPath in the 4th quarter worth $29,000. ORG Partners LLC increased its holdings in UiPath by 875.6% in the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock worth $27,000 after acquiring an additional 1,112 shares in the last quarter. Finally, GAMMA Investing LLC purchased a new stake in shares of UiPath during the fourth quarter worth $36,000. Hedge funds and other institutional investors own 62.50% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on the stock. BMO Capital Markets dropped their target price on shares of UiPath from $28.00 to $14.00 and set a “market perform” rating for the company in a report on Monday, June 3rd. Evercore ISI dropped their target price on shares of UiPath from $27.00 to $13.00 and set an “in-line” rating for the company in a report on Thursday, May 30th. Canaccord Genuity Group dropped their target price on shares of UiPath from $30.00 to $19.00 and set a “buy” rating for the company in a report on Friday, May 31st. KeyCorp reaffirmed a “sector weight” rating on shares of UiPath in a report on Thursday, May 30th. Finally, William Blair lowered shares of UiPath from an “outperform” rating to a “market perform” rating in a report on Thursday, May 30th. Sixteen research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, UiPath has a consensus rating of “Hold” and an average price target of $18.06.
Insider Transactions at UiPath
In other news, CFO Ashim Gupta sold 40,000 shares of the stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $19.79, for a total transaction of $791,600.00. Following the sale, the chief financial officer now owns 946,848 shares of the company’s stock, valued at $18,738,121.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 22.37% of the company’s stock.
UiPath Trading Up 1.3 %
NYSE PATH traded up $0.16 during trading hours on Friday, reaching $12.36. The company had a trading volume of 7,086,519 shares, compared to its average volume of 9,304,966. The stock has a 50-day moving average of $13.30 and a 200 day moving average of $19.06. UiPath Inc. has a 1-year low of $11.07 and a 1-year high of $27.87. The stock has a market capitalization of $7.08 billion, a P/E ratio of -77.25 and a beta of 0.86.
UiPath (NYSE:PATH – Get Free Report) last posted its earnings results on Wednesday, May 29th. The healthcare company reported ($0.03) EPS for the quarter, meeting analysts’ consensus estimates of ($0.03). UiPath had a negative net margin of 6.41% and a negative return on equity of 2.97%. The company had revenue of $335.11 million for the quarter, compared to analysts’ expectations of $332.84 million. As a group, sell-side analysts predict that UiPath Inc. will post -0.22 EPS for the current year.
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Articles
- Five stocks we like better than UiPath
- Best Stocks Under $10.00
- Is Crypto Cool Again? What Stocks You Should Be Watching
- ESG Stocks, What Investors Should Know
- Why Call Options Volume for These 2 Stocks Spiked Together
- How Investors Can Find the Best Cheap Dividend Stocks
- MarketBeat Week in Review – 7/22 – 7/26
Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATH – Free Report).
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.